Who Paid My Doc
Induction Study #2 - A Phase 3, Multicenter, Rando
Research payments
$592,530
Through program year 2022, $592,530 in research payments was reported against Induction Study #2 - A Phase 3, Multicenter, Rando, across 62 payments, paid by Celgene Corporation.
- Paid by
- Celgene Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $46,013 | 7 |
| 2021 | Research | $546,518 | 55 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mohammad Jamal Corona, CA Named on 3 payments
- Jeff Bullock San Antonio, TX Named on 3 payments
- Ricardo McCall Lake Charles, LA Named on 3 payments
- Syed Mumtaz Kissimmee, FL Named on 2 payments
- Aaron Fieker Tulsa, OK Named on 2 payments
- Hubert Reyes Evansville, IN Named on 2 payments
- David Rausher Decatur, GA Named on 2 payments
- Monika Fischer Indianapolis, IN Named on 2 payments
- Curtis Baum Topeka, KS Named on 1 payment
- Anita Afzali Cincinnati, OH Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.